Covance to Present at The R.W. Baird 2008 Growth Stock Conference

PRINCETON, N.J., May 12 Covance Inc. (NYSE: CVD)today announced that it will present at the R.W. Baird 2008 Growth StockConference on Tuesday, May 13, 2008 at 10:30 am ET. Investors may access alive webcast of the presentation at www.covance.com. In order to register anddownload any necessary software, please log on 10 minutes early.

Covance, with headquarters in Princeton, New Jersey, is one of the world'slargest and most comprehensive drug development services companies with annualrevenues greater than $1.5 billion, global operations in more than 20countries, and more than 8,900 employees worldwide. Information on Covance'sproducts and services, recent press releases, and SEC filings can be obtainedthrough its website at www.covance.com.

SOURCE Covance Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...